Interius Gets Go-Ahead for Phase I Trial of In Vivo CAR-T Therapy in Australia
BioSpace
JULY 10, 2024
Interius BioTherapeutics has received approval from Australia’s Human Research Ethics Committee to begin the first-in-human trial of an investigational in vivo CAR-T therapy designed to treat B-cell malignancies.
Let's personalize your content